3,923 results match your criteria: "Folliculitis"
Cureus
November 2024
Internal Medicine, National Medical Center 21st Century, Ciudad de México, MEX.
folliculitis (MF) is a fungal infection that often presents with pruritic follicular papules and pustules, primarily affecting the upper body. Due to its clinical similarity to bacterial folliculitis, misdiagnosis and delayed treatment are common. In this report, we present the case of a 16-year-old male who developed persistent pruritic papules on his upper back and chest, initially misdiagnosed as bacterial folliculitis.
View Article and Find Full Text PDFJ Dermatol
December 2024
Department of Dermatology, Japanese Red Cross Otsu Hospital, Otsu, Shiga, Japan.
JAAD Case Rep
December 2024
Department of Dermatology, University of Connecticut School of Medicine, Farmington, Connecticut.
Ann Dermatol
December 2024
Department of Dermatology, College of Medicine, Dankook University, Cheonan, Korea.
Background: Hair transplantation (HT) has been reported to be effective for the treatment of female-pattern hair loss (FPHL). Few studies have investigated HT in FPHL.
Objective: To evaluate the clinical features of FPHL treated with HT and analyze the real-world results of HT.
Cureus
October 2024
Obstetrics and Gynaecology, Dr. D. Y. Patil Medical College, Hospital and Research Centre, Dr. D. Y. Patil Vidyapeeth (Deemed to be University), Pune, IND.
Actas Dermosifiliogr
November 2024
Servicio de Dermatología, Centro Dermatológico Dr. Ladislao de la Pascua, Ciudad de México, México; Servicio de Dermatología, Hospital Universitario Severo Ochoa, Madrid, España; Trichology Unit, Grupo de Dermatología Pedro Jaén, Madrid, España; Servicio de Dermatología, Hospital Universitario Ramón y Cajal; Departamento de Biología de Sistemas, Facultad de Medicina, Universidad de Alcalá, IRYCIS, Madrid, España.
Acne keloidalis nuchae (AKN) is a chronic inflammatory dermatosis of the scalp that causes scarring alopecia. The etiology of AKN has been associated with an immune response vs. follicular antigens.
View Article and Find Full Text PDFUgeskr Laeger
October 2024
Afdelingen for Hud- og Kønssygdomme, Aarhus Universitetshospital.
EMBO Mol Med
December 2024
Center for Cancer Research, Medical University of Vienna and Comprehensive Cancer Center, Vienna, 1090, Austria.
The hair follicle stem cell niche is an immune-privileged microenvironment, characterized by reduced antigen presentation, thus shielding against permanent immune-mediated tissue damage. In this study, we demonstrated the protective role of hair follicle-specific epidermal growth factor receptor (EGFR) against scarring hair follicle destruction. Mechanistically, disruption of EGFR signaling generated a cell-intrinsic hypersensitivity within the JAK-STAT1 pathway, which, synergistically with interferon gamma expressing CD8 T-cell and NK-cell-mediated inflammation, compromised the stem cell niche.
View Article and Find Full Text PDFEMBO Mol Med
December 2024
Department of Dermatology, Department of Cell and Developmental Biology, University of Michigan, Ann Arbor, MI, 48109, USA.
The hair follicle is thought to be a site of ‘immune privilege,’ or relative protection from autoimmune and inflammatory responses. In particular, the long-lived, quiescent hair follicle stem cells (HFSCs) are strikingly resistant to cytotoxic immune effectors such as T cells and natural killer (NK) cells, even in systems where these cells are artificially directed to attack HFSCs. Nonetheless, many forms of alopecia are associated with immune-mediated damage of the hair follicle epithelium, suggesting a failure of immune privilege.
View Article and Find Full Text PDFPediatr Dermatol
November 2024
Ronald O. Perelman Department of Dermatology, New York University Grossman School of Medicine, New York, New York, USA.
Background: Binimetinib and selumetinib are two mitogen-activated protein kinase kinase (MEK) inhibitors used to treat low-grade gliomas and plexiform neurofibromas. Cutaneous toxicities are commonly associated with MEK inhibitors; however, limited studies have examined cutaneous effects in a pediatric population or whether toxicities vary between MEK inhibitors.
Methods: We conducted an IRB-approved, single-center, retrospective review of pediatric neuro-oncology patients on binimetinib or selumetinib who presented to NYU from April 2016 through July 2022.
J Cutan Pathol
November 2024
Oakland University William Beaumont School of Medicine, Rochester Hills, Michigan, USA.
Background: Folliculotropic mycosis fungoides (FMF) is a rare cutaneous malignancy that can be mistaken for inflammatory diseases, such as discoid lupus erythematosus (DLE), due to the variability of histopathological findings.
Methods: This study aims to provide dermatopathologists with evidence-based histopathologic criteria to distinguish DLE from FMF by reporting overlapping and distinguishing microscopic features. Forty-three biopsies from patients with a confirmed diagnosis of DLE or FMF were graded for the presence or absence of 18 histopathologic features.
Arch Dermatol Res
November 2024
Department of Dermatology, Wake Forest University School of Medicine, Winston-Salem, NC, USA.
Aust Vet J
October 2024
Gribbles Veterinary Pathology, Clayton, Victoria, 3168, Australia.
Cureus
September 2024
Department of Anatomy, Miyazaki University, Miyazaki, JPN.
Aesthetic Plast Surg
October 2024
Department of Plastic and Aesthetic Surgery, Nanfang Hospital of Southern Medical University, Guangzhou, 510515, Guangdong Province, China.
Background: Conventional epilation methods commonly encounter challenges in achieving permanent removal of unwanted facial terminal hair (uFTH), particularly when it is interspersed among normal hairs.
Objective: To assess the safety and effectiveness of follicular unit excision (FUE) for permanent removal of uFTH.
Methods: The retrospective analysis included 231 patients who underwent FUE hair removal at three medical centers.
J Cutan Pathol
January 2025
Dr. Phillip Frost Department of Dermatology and Cutaneous Surgery, University of Miami Miller School of Medicine, Miami, Florida, USA.
JAAD Case Rep
November 2024
Division of Allergy, Pulmonary and Critical Care Medicine, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee.
Dermatol Ther (Heidelb)
November 2024
Institute for Health Services Research in Dermatology and Nursing (IVDP), University Medical Center Hamburg-Eppendorf (UKE), Martinistraße 52, 20246, Hamburg, Germany.
Cutis
September 2024
Clinical Assistant Professor (Adjunct), Department of Urban Health and Population Science, Center for Urban Bioethics, Lewis Katz School of Medicine at Temple University, Philadelphia, Pennsylvania.
JAAD Case Rep
October 2024
Department of Dermatology, University of Texas Southwestern Medical Center, Dallas, Texas.
J Community Hosp Intern Med Perspect
September 2024
Department of Emergency Medicine and General Internal Medicine, Fujita Health University School of Medicine, Toyoake, Aichi, Japan.
Internal jugular vein (IJV) thrombosis is a rare and potentially life-threatening condition commonly caused by central venous catheter insertion, malignant tumors, and neck infections. A 45-year-old woman with an unremarkable medical history presented with left neck pain. Imaging studies of a suspected mediastinal tumor revealed IJV thrombosis.
View Article and Find Full Text PDFDermatol Pract Concept
October 2024
Corso di Clinica Dermatologica, Università di Milano Bicocca e Ospedale San Raffaele, Milano.
Clin Exp Dermatol
October 2024
Department of Dermatology, Hospital das Clínicas, University of São Paulo Medical School, São Paulo, Brazil.
Cureus
September 2024
Pediatrics, El Paso Kids Klinic, El Paso, USA.
Indian Dermatol Online J
August 2024
Department of Dermatology and STD, National Institute of Medical Sciences and Research, Jaipur, Rajasthan, India.